Wnt/β-catenin signaling is a therapeutic target in anaplastic thyroid carcinoma
Diana B. Díaz(Vanderbilt University Medical Center), Vivian Weiß(Vanderbilt University Medical Center), Heather Hartmann(Vanderbilt University Medical Center), James L. Netterville(Breast Cancer Research Foundation), Jeremy A. Goettel(Vanderbilt University Medical Center), Sarah L. Rohde(Vanderbilt University Medical Center), Megan L. Tigue(Vanderbilt University Medical Center), Courtney J. Phifer(Vanderbilt University Medical Center), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Ethan Lee(Johns Hopkins University), Fei Ye(Vanderbilt University Medical Center), George J Xu(Vanderbilt University Medical Center), Jamal M Byrant(Vanderbilt University), Matthew A Loberg(Vanderbilt University Medical Center), Naira Baregamian(Vanderbilt University Medical Center), Quanhu Sheng(Vanderbilt University Medical Center), Kensey Bergdorf(Vanderbilt University)
Cited by 15
Related Papers
The structure of the G protein heterotrimer Giα1β1γ2
|Cell|1995|1.1k
The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway
|PLoS Biology|2003|724
Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas
|Journal of Clinical Oncology|2006|572
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
|Nature Chemical Biology|2010|488